Steven Bulera, PhD, DABT
Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment
Bio:
Dr Steven Bulera, PhD, DABT, has more than 25 years in the pharmaceutical industry. He has been at Charles River since 2007 and has served as the Head of Toxicology at both the Shrewsbury, MA and Reno, NV sites, and as the Global Head of Toxicology. Currently, Steven is the Corporate Vice President, Chief Scientific Officer, Discovery and Safety Assessment. Prior to Charles River, Steven held positions at 3 pharmaceutical companies: Parke-Davis, Pfizer, and Bristol-Myers Squibb. He has experience as an in vivo study director, has been the Head of Genetic Toxicology, and has led an investigational toxicology group with experience in the panomic technologies (toxicogenomics, proteomics, metabonomics). He also has experience in drug development and has worked on numerous drug candidates being developed for oncology and anti-HIV therapies.
Steven holds degrees in biochemistry from Canisius College (B.A.) and The University of Connecticut (M.S./Ph.D.). Steven was a postdoctoral fellow in Dr. Henry Pitot’s laboratory at the McArdle Laboratory for Cancer Research at the University of Wisconsin. He is a current member of the American College of Toxicology and the Society of Toxicology. Steven has been a Diplomat of the American Board of Toxicology since 1998.